Evidence map›Paper›PMID 40533350›Full record

ArticleAJNR. American journal of neuroradiology2025

Can CTA-Based Machine Learning Identify Patients for Whom Successful Endovascular Stroke Therapy Is Insufficient?

Jerome A Jeevarajan, Yingjun Dong, Anjan Ballekere, Sergio Salazar Marioni, Arash Niktabe, Rania Abdelkhaleq, Sunil A Sheth, Luca Giancardo

Abstract readMulticenter Study
In one paragraph

Article in AJNR. American journal of neuroradiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jerome A JeevarajanFrom the Department of Neurology (J.A.J., Y.D., A.B., S.S.M., A.N., R.A., S.A.S., L.G.), McGovern Medical School, The University of Texas Health Houston, Houston, Texas.ORCID https://orcid.org/0000-0002-6285-9350
Yingjun DongFrom the Department of Neurology (J.A.J., Y.D., A.B., S.S.M., A.N., R.A., S.A.S., L.G.), McGovern Medical School, The University of Texas Health Houston, Houston, Texas.
Anjan BallekereFrom the Department of Neurology (J.A.J., Y.D., A.B., S.S.M., A.N., R.A., S.A.S., L.G.), McGovern Medical School, The University of Texas Health Houston, Houston, Texas.
Sergio Salazar MarioniFrom the Department of Neurology (J.A.J., Y.D., A.B., S.S.M., A.N., R.A., S.A.S., L.G.), McGovern Medical School, The University of Texas Health Houston, Houston, Texas.
Arash NiktabeFrom the Department of Neurology (J.A.J., Y.D., A.B., S.S.M., A.N., R.A., S.A.S., L.G.), McGovern Medical School, The University of Texas Health Houston, Houston, Texas.
Rania AbdelkhaleqFrom the Department of Neurology (J.A.J., Y.D., A.B., S.S.M., A.N., R.A., S.A.S., L.G.), McGovern Medical School, The University of Texas Health Houston, Houston, Texas.
Sunil A ShethFrom the Department of Neurology (J.A.J., Y.D., A.B., S.S.M., A.N., R.A., S.A.S., L.G.), McGovern Medical School, The University of Texas Health Houston, Houston, Texas.
Luca GiancardoFrom the Department of Neurology (J.A.J., Y.D., A.B., S.S.M., A.N., R.A., S.A.S., L.G.), McGovern Medical School, The University of Texas Health Houston, Houston, Texas luca.giancardo@uth.tmc.edu.

Funding

Addressing the paradox of poor outcomes despite successful recanalization in strokeR01NS138765 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Santiago Ortega-Gutierrez, Sunil Sheth · 2024 to 2026
$1.6M
Research Training for Residents & Fellows in Neurological DisordersUE5NS113757 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Samden Lhatoo, NITIN TANDON · 2024 to 2026
$353k
NINDS NIH HHS R01 NS138765NINDS NIH HHS UE5 NS113757
6 · The paper itself

Abstract

background and purposeDespite advances in endovascular stroke therapy (EST) devices and techniques, many patients are left with substantial disability, even if the final infarct volumes (FIVs) remain small. Here, we evaluate the performance of a machine learning (ML) approach by using pretreatment CTA to identify this cohort of patients that may benefit from additional interventions. MATERIALS AND

methodsWe identified consecutive subjects with large vessel occlusion (LVO) acute ischemic stroke (AIS) who underwent EST with successful reperfusion in a multicenter prospective registry cohort. We included only subjects with FIV < 30 mL and recorded 90-day outcome (mRS). A deep learning model was pretrained and then fine-tuned to predict 90-day mRS 0-2 by using pretreatment CTA images (DeepsymNet-v3 model pretrained on radiology reports and fine-tuned on detection of unexpected clinical outcomes using brain CTA images [DSN-CTA] model). The primary outcome was the predictive performance of the DSN-CTA model compared with a logistic regression model with clinical variables, measured by the area under the receiver operating characteristic curve (AUROC).

resultsThe DSN-CTA model was pretrained on 1542 subjects and then fine-tuned and cross-validated with 48 subjects, all of whom underwent EST with TICI 2b-3 reperfusion. Of this cohort, 56.2% of subjects had 90-day mRS 3-6 despite successful EST and FIV < 30 mL. The DSN-CTA model showed significantly better performance than a model with clinical variables alone when predicting good 90-day mRS (AUROC 0.81 versus 0.492;

conclusionsThe CTA-based ML model was able to more reliably predict unexpected poor functional outcome after successful EST and small FIV for patients with LVO AIS compared with standard clinical variables. ML models may identify a priori patients in whom EST-based LVO reperfusion alone is insufficient to improve clinical outcomes.

Indexed as

Cerebral AngiographyComputed Tomography AngiographyEndovascular ProceduresIschemic StrokeMachine LearningStrokeAgedAged, 80 and overFemaleHumansMaleMiddle AgedProspective StudiesRegistriesTreatment Outcome

Identifiers

PMID40533350
PMCPMC12687980

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.